Catalysts for Baxter Healthcare Corp
370 tracked
Aug 15, 2025
device 510k
Beckman Coulter, Inc. — MicroScan Dried Gram-Positive MIC/Combo Panels with Daptomycin (DAP) (0.06-32 µg/mL) (510k cleared)
Baxter Healthcare Corp
→
Aug 8, 2025
device recall
Baxter Healthcare Corporation device recall (Cls II)
Baxter Healthcare Corp
→
Aug 4, 2025
device recall
Baxter Healthcare Corporation device recall (Cls I)
Baxter Healthcare Corp
→
Aug 4, 2025
device recall
Baxter Healthcare Corporation device recall (Cls I)
Baxter Healthcare Corp
→
Aug 4, 2025
device recall
Baxter Healthcare Corporation device recall (Cls I)
Baxter Healthcare Corp
→
Jul 28, 2025
device 510k
Baxter Healthcare Corporation — Spectrum IQ Infusion System with Dose IQ Safety Software (3570009) (510k cleared)
Baxter Healthcare Corp
→
Jul 28, 2025
device 510k
Baxter Healthcare Corporation — SIGMA Spectrum Infusion Pump with Master Drug Library (510k cleared)
Baxter Healthcare Corp
→
Jul 14, 2025
device recall
Baxter Healthcare Corporation device recall (Cls II)
Baxter Healthcare Corp
→
Jul 14, 2025
device recall
Baxter Healthcare Corporation device recall (Cls I)
Baxter Healthcare Corp
→
Jul 10, 2025
device pma
Baxter Healthcare Corporation — Preveleak Surgical Sealant (PMA supplement)
Baxter Healthcare Corp
→
Jun 30, 2025
device pma
Baxter Healthcare Corp — FLOSEAL MATRIX/FLOSEAL MATRIX HEMOSTATIC SEALANT/PROCEED HEMOSTATIC SEALANT (PMA supplement)
Baxter Healthcare Corp
→
May 7, 2025
recall
Mckesson Medical-Surgical Inc. Corporate Office recall (Cls II)
Baxter Healthcare Corp
→
Mar 14, 2025
device 510k
Baxter Healthcare Corporation — Solution Administration Sets (510k cleared)
Baxter Healthcare Corp
→
Feb 28, 2025
device 510k
Baxter Healthcare Corporation — Intravascular Extension Sets and Accessories (510k cleared)
Baxter Healthcare Corp
→
Feb 28, 2025
approval
EPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE (EPINEPHRINE BITARTRATE) — FDA approval
epinephrine bitartrate
→
Nov 13, 2024
recall
Baxter Healthcare Corporation recall (Cls II)
Baxter Healthcare Corp
→
Oct 30, 2024
recall
Fresenius Kabi Compounding, LLC recall (Cls II)
Baxter Healthcare Corp
→
Oct 30, 2024
recall
Fresenius Kabi Compounding, LLC recall (Cls II)
Baxter Healthcare Corp
→
Aug 30, 2024
approval
SEVOFLURANE — FDA approval
SEVOFLURANE
→
Jul 24, 2024
approval
LACTATED RINGER'S IN PLASTIC CONTAINER (CALCIUM CHLORIDE) — FDA approval
CALCIUM CHLORIDE 10%
→
Jun 11, 2024
approval
NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE (NOREPINEPHRINE BITARTRATE) — FDA approval
NOREPINEPHRINE BITARTRATE
→
Nov 23, 2023
approval
NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE (NOREPINEPHRINE BITARTRATE) — FDA approval
NOREPINEPHRINE BITARTRATE
→
Jun 15, 2023
approval
BREVIBLOC (ESMOLOL HYDROCHLORIDE) — FDA approval
ESMOLOL HYDROCHLORIDE
→
Jun 2, 2022
approval
NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE (NOREPINEPHRINE BITARTRATE) — FDA approval
NOREPINEPHRINE BITARTRATE
→
Jun 2, 2022
approval
NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE (NOREPINEPHRINE BITARTRATE) — FDA approval
NOREPINEPHRINE BITARTRATE
→
May 10, 2022
approval
MAGNESIUM SULFATE — FDA approval
MAGNESIUM SULFATE
→
May 6, 2022
approval
DOXIL (LIPOSOMAL) (DOXORUBICIN HYDROCHLORIDE) — FDA approval
Doxil
→
Nov 3, 2021
approval
LACTATED RINGER'S IN PLASTIC CONTAINER (CALCIUM CHLORIDE) — FDA approval
Baxter Healthcare Corp
→
Nov 3, 2021
approval
DEXTROSE 5% IN LACTATED RINGER'S IN PLASTIC CONTAINER (CALCIUM CHLORIDE) — FDA approval
Baxter Healthcare Corp
→
Jan 15, 2021
approval
NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE (NOREPINEPHRINE BITARTRATE) — FDA approval
NOREPINEPHRINE BITARTRATE
→